Catalyst Pharmaceuticals Inc Earnings

Catalyst Pharmaceuticals Inc’s revenue jumped 25.33% since last year same period to $128.7Mn in the Q3 2024. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 4.88% jump in its revenue since last 3-months.

Catalyst Pharmaceuticals Inc’s net profit jumped 242.65% since last year same period to $43.88Mn in the Q3 2024. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 7.57% jump in its net profits since last 3-months.

Catalyst Pharmaceuticals Inc’s net profit margin jumped 213.82% since last year same period to 34.1% in the Q3 2024. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 2.57% jump in its net profit margins since last 3-months.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.32 - a 6.67% jump from last quarter’s estimates.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.32.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) jumped 220.69% since last year same period to 0.35 in the Q3 2024. This indicates that the Catalyst Pharmaceuticals Inc has generated 220.69% annual rate of jump in its earning per share (EPS) in the last 4 quarters.